Projects per year
Abstract
INTRODUCTION: Frailty is a common geriatric syndrome that adversely impacts health outcomes. This study examined correlates of physical frailty in healthy community-dwelling older adults and studied the effect of frailty on disability-free survival (DFS), defined as survival free of independence-limiting physical disability or dementia. METHODS: This is a post hoc analysis of 19,114 community-dwelling older adults (median age: 74.0 years, interquartile range or IQR: 6.1 years) from Australia and the USA enrolled in the "ASPirin in Reducing Events in the Elderly (ASPREE)" clinical trial. Frailty was assessed using a modified Fried phenotype and a deficit accumulation frailty index (FI) utilizing a ratio score derived from 66 items. Multinomial logistic regression was used to examine the correlates of frailty and Cox regression to analyze the association between frailty and DFS (and its components). RESULTS: At study enrollment, 39.0% were prefrail, and 2.2% of participants were frail, according to Fried phenotype. Older age, higher waist circumference, lower education, ethnoracial origin, current smoking, depression, and polypharmacy were associated with prefrailty and frailty according to Fried phenotype and FI. Fried phenotype defined prefrailty and frailty predicted reduced DFS (prefrail: HR: 1.67; 95% CI: 1.50-1.86 and frail: HR: 2.80; 95% CI: 2.27-3.46), affecting each component of DFS including dementia, physical disability, and mortality. Effect sizes were larger, according to FI. CONCLUSION: Our study showed that prefrailty is common in community-dwelling older adults initially free of cardiovascular disease, dementia, or independence-limiting physical disability. Prefrailty and frailty significantly reduced disability-free survival. Addressing modifiable correlates, like depression and polypharmacy, might reduce the adverse impact of frailty on dementia-free and physical disability-free survival.
| Original language | English |
|---|---|
| Pages (from-to) | 549-560 |
| Number of pages | 12 |
| Journal | Gerontology |
| Volume | 69 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- ASPirin in Reducing Events in the Elderly
- Dementia
- Disability-free survival
- Frailty index
- Fried phenotype
- Physical disability
Projects
- 3 Finished
-
Comprehensive risk prediction models and presymptomatic biomarkers for dementia
Ryan, J. (Primary Chief Investigator (PCI))
NHMRC - National Health and Medical Research Council (Australia)
1/09/17 → 31/12/22
Project: Research
-
ASPREE Completion Project
McNeil, J. (Primary Chief Investigator (PCI)), Nelson, M. (Chief Investigator (CI)), Tonkin, A. (Chief Investigator (CI)) & Woods, R. (Chief Investigator (CI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/16 → 31/12/18
Project: Research
-
A randomised double-blind placebo-controlled trial of aspirin in primary prevention of CVD events or dementia in the aged ID: 334047
McNeil, J. (Primary Chief Investigator (PCI)), Beilin, L. J. (Chief Investigator (CI)), Krum, H. (Chief Investigator (CI)), Nelson, M. (Chief Investigator (CI)), Reid, C. (Chief Investigator (CI)) & Tonkin, A. (Chief Investigator (CI))
NHMRC - National Health and Medical Research Council (Australia)
1/01/05 → 31/12/09
Project: Research
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver